MannKind Corp
About
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Growth
MannKind Corporation is an established enterprise in the biopharmaceutical industry, focusing on developing cutting-edge therapies and technologies to improve people's lives. With a strong foundation and a proven track record of success, the company continues to advance its pipeline of innovative products and expand its reach globally.
Achievements
Over the years, MannKind Corporation has achieved significant milestones, such as the successful development and commercialization of Afrezza® Inhalation Powder for the treatment of both type 1 and type 2 diabetes mellitus in adults. The company also expanded its international presence by launching the product in countries like Brazil and India through strategic partnerships. Additionally, MannKind Corporation has diversified its product portfolio to address other medical conditions, including pulmonary arterial hypertension, nontuberculous mycobacterial lung disease, idiopathic pulmonary fibrosis, and cystic fibrosis.
Case Studies
One notable case study involving MannKind Corporation is the successful development and commercialization of Afrezza® Inhalation Powder, which has revolutionized the treatment of diabetes mellitus by offering a convenient and effective insulin delivery option. The company's partnership with United Therapeutics to develop Tyvaso DPI® for pulmonary arterial hypertension further demonstrates its commitment to addressing unmet medical needs and enhancing patient outcomes. These case studies underscore MannKind Corporation's expertise in translating scientific innovation into real-world solutions.
Socials
Website
Founded
-
Operating Status
Active
Industry
Health Care/Life Sciences
headquarters
Address
1 Casper Street Danbury Connecticut 06810 United States...
Country
United States
Employees
414
Key People
Kent Kresa (Independent Director)
Lauren M. Sabella (Chief Operating Officer & Executive Vice President)
Christopher B. Prentiss (Chief Financial & Accounting Officer)
Revenue
198.96 M
Operating Income
Stock Price
$6.54
Why Setting Up a Virtual Delivery Center (VDC) Is Critical for Your Company’s Success
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC
Similar Companies
Welcome to AiDOOS Wiki
AiDOOS Information Wiki provides comprehensive information about products, companies, and individuals.
MannKind Corp
-
Website
-
Founded
-
-
Industry
Health Care/Life Sciences
-
Address
1 Casper Street Danbury Connecticut 06810 United States...
-
Country
United States
-
Number of employees
414+
-
Revenue
198.96 M
About MannKind Corp
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Why Setting Up a Virtual Delivery Center (VDC) Is Critical for Your Company’s Success
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC
